Processed version of the MaxQuant phosphosite table of the experiments with tirabrutinib-treated U-2932 cells.

For all confidently localized phosphorylation sites (localization probability ≥0.75%), SILAC ratios of individual replicate experiments are reported. Class 1 site ratios that were reproducibly identified are indicated and further marked as regulated in case of consistent up- or downregulation. The tirabrutinib/control phosphosite ratios from Experiment 2 correspond to the normalized and inverted H/L ratio due to the introduced label switch compared to Experiment 1. (XLSX)